ArticleOral Propranolol Used as Adjunct Therapy in Cutaneous AngiosarcomaAuthor:David M. Perry, MD, PhDPublish date: January 5, 2023Although cutaneous angiosarcoma typically portends a poor prognosis at the time of diagnosis, adjunctive oral propranolol may be a promising and re...Read More
